Acquired Methemoglobinemia

A young woman in Rhode Island came to the doctors and said that she was “blue,” and she meant it literally. Doctors analysed her physically and they were able to see the bluish coloration of her skin. When doctors drew blood from the patient’s arteries, it appeared dark blue instead of the normal bright red.

A 25-year-old woman presented to the emergency department with a 1-day history of generalized weakness, fatigue, shortness of breath, and skin discoloration.

On examination:

  • She had a respiratory rate of 22 breaths per minute and an oxygen saturation of 88% while breathing ambient air.
  • The oxygen saturation value displayed on the pulse oximeter did not improve with the administration of supplemental oxygen.
  • The patient appeared cyanotic (Panel A), and she had dark arterial and venous blood (Panel B, smaller tube and larger tube, respectively).
  • Measurements of arterial blood gases included a partial pressure of arterial oxygen of 120 mm Hg and a calculated oxygen saturation of 100%.
  • The percentage of methemoglobin was 44%.

After thorough examination, she was diagnosed with Methemoglobinemia. The condition can cause bluish skin and blood.

She was treated with intravenous methylene blue and had considerable improvement in her breathing and reduction in skin discoloration.

She reported having used large amounts of topical benzocaine the night before for a toothache. Thus, it could be a reaction to her medicine.

Methemoglobinemia can occur after exposure to a number of medications, including topical anesthetic agents such as benzocaine. It could be an inherited metabolic disorder.


Reference

Warren OU, Blackwood B. Acquired Methemoglobinemia. New England Journal of Medicine. 2019 Sep 19;381(12):1158-.

Share it with
Email
Facebook
LinkedIn
Twitter
WhatsApp

Similar Articles

Data Privacy Notice

This Privacy Notice shall be read in conjunction with the Privacy Policy to the extent this Notice does not mention or specify the particulars that should have been mentioned or specified relating to the Notice in pursuance of the provisions of the Data Protection Laws as applicable.

On having accessed or visited this Platform you the Noticee hereby voluntarily consent to and take notice of the fact that the personal data, by which or in relation whereto you the concerned Noticee is identifiable, shall be retained, stored, used, and may be processed by the Company for the purpose and in the manner, though legal, found suitable to it for commercial and/or some other reasons. The detailed specificity whereof may be found in the Privacy Policy. The consent provided herein may be withdrawn anytime by you, the Noticee, at its own volition by removing your profile or by writing to us at support@docquity.com.

As a Noticee, you shall have the right to grievance redressal, in relation to your consent or our use of your personal data, which you may address by writing to us at dpo@docquity.com. Should you, the Noticee, thereafter remain unsatisfied or dissatisfied with the resolution provided by us, you, the Noticee, may approach the concerned regulatory authority for the redressal of your grievance.

Thanks for exploring our medical content.

Create your free account or log in to continue reading.

Data Privacy Notice

By using this platform, you consent to our use of your personal data as detailed in our Privacy Policy, and acknowledge that we use cookies to improve your browsing experience